Research News
Research News
BrightFocus-funded Dr. Maya Koronyo-Hamaoui is the senior author on a groundbreaking publication that reported the ACE protein, which can increase blood pressure to dangerous levels in the body’s blood stream, can actually help to clear beta-amyloid in the brain by stimulating the immune system.
Jun 30, 2015
Research News
Experts have long recognized that the number of deaths from Alzheimer’s disease (AD) tends to be underreported. Now a new study published in Neurology attempts to quantify that under-reporting and projects the AD mortality rate to be five to six times higher than official estimates, suggesting that AD may be responsible for more than 500,000 annual deaths in the United States.
Jun 30, 2015
Alzheimer's Disease Research
Blood-Based Biomarkers Seen as Breakthrough for Early Diagnosis and Treatment of Alzheimer’s Disease
Blood-Based Biomarkers Seen as Breakthrough for Early Diagnosis and Treatment of Alzheimer’s Disease
Jun 30, 2015
Clinical Trials
Newly-Studied REST Protein Provides More Clues to Cause of Alzheimer’s Disease
Jun 30, 2015
Clinical Trials
A group of researchers based at the University of California, San Francisco (UCSF), have shown that when cardiovascular risk factors (CVRF) such as elevated glucose and high blood pressure begin in early adulthood, they are associated with significantly worse cognitive function in middle age compared with having no CVRF.
Jun 30, 2015
Clinical Trials
University of California, Irvine (UCI) researchers, led by BrightFocus researcher Frank M. LaFerla, PhD, have published positive findings from mice studies that suggest cell therapy slows down brain changes and symptoms linked to Alzheimer’s disease.
Jun 30, 2015
Alzheimer's Disease Research
Exciting news travels from Washington University of St. Louis (WUSL), where two BrightFocus-funded Alzheimer’s researchers recently had their results published in major scientific journals. Both projects were directly funded by BrightFocus.
Jun 30, 2015
Clinical Trials
A large clinical trial aimed at screening and early treatment for Alzheimer’s disease holds the potential to be groundbreaking—if enough volunteers can be recruited to get it off the ground.
Jun 30, 2015
There’s been a steady stream of news from the Alzheimer’s Association International Conference (AAIC) in Copenhagen, held July 12-17, 2014. The international summit brings together 4,500 professionals from 80 countries involved in Alzheimer’s treatment, patient care, and research.
Jun 30, 2015
Drugs & Medication
Recently, the BrightFocus Foundation awarded an Alzheimer’s Disease Research Fellowship to Soong Ho Kim, PhD, at Mount Sinai Hospital in New York City, to study whether a new drug could directly attack symptoms of Alzheimer's disease, but also work to address the disease process. A new study in Molecular Psychiatry now provides evidence that this line of research may be progressing."
Jun 29, 2015
